Tudor Investment Corp
ABCL icon

Tudor Investment Corp’s AbCellera Biologics ABCL Stock Holding History

Tudor Investment Corp’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.93M Buy
2,273,489
+477,479
+27% +$1.72M 0.01% 874
2025
Q4 		$6.14M Buy
1,796,010
+1,065,888
+146% +$4.76M 0.01% 1031
2025
Q3 		$3.67M Buy
+730,122
New +$3.22M 0.01% 1402
2024
Q3 		– Sell
-236,649
Closed -$700K – 2642
2024
Q2 		$700K Buy
236,649
+145,915
+161% +$552K ﹤0.01% 1651
2024
Q1 		$411K Buy
+90,734
New +$463K ﹤0.01% 1733
2023
Q4 		– Sell
-20,105
Closed -$92.5K – 2297
2023
Q3 		$92.5K Buy
20,105
+1,858
+10% +$11.3K ﹤0.01% 2154
2023
Q2 		$118K Buy
18,247
+175
+1% +$1.19K ﹤0.01% 2285
2023
Q1 		$136K Buy
18,072
+2,424
+15% +$22K ﹤0.01% 2226
2022
Q4 		$159K Buy
15,648
+402
+3% +$4.64K ﹤0.01% 2169
2022
Q3 		$151K Buy
15,246
+4,977
+48% +$54.6K ﹤0.01% 2125
2022
Q2 		$109K Sell
10,269
-10,840
-51% -$91.8K ﹤0.01% 1912
2022
Q1 		$206K Buy
+21,109
New +$200K ﹤0.01% 1758
2021
Q4 		– Sell
-15,121
Closed -$303K – 2310
2021
Q3 		$303K Sell
15,121
-64,603
-81% -$1.14M ﹤0.01% 2029
2021
Q2 		$1.75M Buy
+79,724
New +$2.2M 0.03% 623

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tudor Investment Corp's ABCL Position: Q1 2026 in Review

Tudor Investment Corp increased its AbCellera Biologics (ABCL) stake by 27% in Q1 2026, buying an estimated $1.72M and bringing the position to 2,273,489 shares worth $7.93M. The position accounts for 0.01% of the portfolio, ranked #874.

Tudor Investment Corp first reported a position in ABCL in Q2 2021 and has held it in 14 quarters since. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Tudor Investment Corp held 2,273,489 shares of AbCellera Biologics worth $7.93M as of Q1 2026.
  • Tudor Investment Corp bought 477,479 AbCellera Biologics shares in Q1 2026, an estimated $1.72M.
  • AbCellera Biologics made up 0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #874 holding.
  • Tudor Investment Corp first reported a position in AbCellera Biologics in Q2 2021 and has held it in 14 quarters since.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.